
What Is 5-Amino-1MQ?
5-Amino-1MQ is a synthetic methylquinolinium compound developed for scientific research into the biological role of nicotinamide N-methyltransferase (NNMT). Unlike peptides, which are composed of amino acid chains, or selective androgen receptor modulators (SARMs), which interact with androgen receptors, 5-Amino-1MQ belongs to an entirely different class of research compounds.
Its primary role in published scientific literature is as a selective inhibitor of NNMT, an enzyme that catalyses the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide (1-MNA). Because this reaction links nicotinamide metabolism with cellular methylation processes, NNMT has become an important area of investigation in metabolic research.
Researchers have explored whether altering NNMT activity influences biological pathways involved in adipocyte function, glucose regulation, liver metabolism and age-related changes in skeletal muscle. As a result, 5-Amino-1MQ has become a widely referenced experimental tool for studying these processes under controlled laboratory conditions.
Current understanding of 5-Amino-1MQ comes primarily from preclinical laboratory research. The studies below summarise the main areas investigated in the published scientific literature.
Research Overview Table
Chemical and Molecular Characteristics
This table provides a summary of the key technical characteristics of 5-Amino-1MQ and its current research classification.
5-Amino-1MQ is a fully synthetic, low-molecular-weight organic compound belonging to the substituted methylquinolinium class. Unlike peptide-based research materials, it does not contain amino acid residues, peptide bonds or higher-order structural features such as secondary folding, cyclisation or disulphide bridges. Its molecular architecture is instead based on a rigid aromatic quinolinium ring system bearing an amino substituent and a permanently charged quaternary nitrogen centre.
The quaternary ammonium group gives the molecule a positive ionic charge across a broad pH range and contributes significantly to its physicochemical behaviour. This structural feature influences properties such as aqueous solubility, chromatographic retention and interaction with negatively charged or polar molecular environments. The aromatic heterocyclic framework also provides a relatively stable and conformationally restricted structure, while the amino functional group creates an additional site for hydrogen bonding and intermolecular interaction.
Chemically, 5-Amino-1MQ is distinct from selective androgen receptor modulators, peptides and naturally occurring nicotinamide derivatives. Its primary experimental relevance arises from its interaction with nicotinamide N-methyltransferase, a cytosolic enzyme involved in nicotinamide methylation and methyl-donor utilisation. The comparatively compact molecular structure of 5-Amino-1MQ has enabled its use in biochemical assays, cell-based systems and preclinical models designed to characterise NNMT activity and associated metabolic pathways.
Since the compound is made by conventional organic synthesis and not by peptide synthesis, its identity is usually ascertained by means of analytical techniques such as high-performance liquid chromatography, liquid chromatography-mass spectrometry and, where appropriate, nuclear magnetic resonance spectroscopy. These methods allow for the verification of chemical purity, molecular mass and structural identity. Although the capsule form offers a pre-measured physical dosage, the compound is still regarded as an experimental research material with no established clinical application in humans.
Certificates:
Mechanism of Action Under Investigation
Published scientific literature has characterised 5-Amino-1MQ as a selective experimental inhibitor of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme responsible for catalysing the methylation of nicotinamide. Within laboratory investigations, the compound has been studied for its ability to interact with the catalytic region of NNMT, thereby reducing the enzymatic conversion of nicotinamide into 1-methylnicotinamide (1-MNA). This molecular interaction forms the basis of ongoing research into the biological role of NNMT and its relationship with cellular metabolism.
NNMT utilises S-adenosyl-L-methionine (SAM) as the methyl donor during catalysis, producing S-adenosyl-L-homocysteine (SAH) alongside 1-MNA. Because this reaction links nicotinamide metabolism with intracellular methyl-donor utilisation, selective inhibition of NNMT has become an important experimental approach for investigating interconnected metabolic pathways. Rather than acting directly upon downstream signalling networks, 5-Amino-1MQ is investigated as a molecular tool that modulates the activity of the upstream enzyme, allowing researchers to examine the biochemical consequences of altered NNMT function under controlled laboratory conditions.
Experimental studies have also examined the changes in intracellular metabolite profiles after NNMT inhibition by means of a number of analytical techniques such as enzyme kinetics, metabolomic profiling, liquid chromatography-mass spectrometry (LC-MS), transcriptomic analysis and molecular biology methods. The various investigations have looked at the effect of changes in NNMT activity on nicotinamide turnover, on the availability of methyl-donors and on broader metabolic processes in a range of experimental systems.
Because NNMT occupies a strategic position at the intersection of one-carbon metabolism, nicotinamide utilisation and cellular methylation, published research has also examined the downstream biological pathways associated with selective enzyme inhibition. Investigations have included adipose tissue biology, hepatic metabolism, skeletal muscle physiology and cellular energy regulation, with the objective of improving scientific understanding of enzyme function rather than establishing therapeutic applications.
Although the molecular interaction between 5-Amino-1MQ and NNMT has been characterised through biochemical and structural investigations, many downstream effects remain the subject of ongoing research. Current evidence is derived predominantly from in vitro experiments and preclinical animal models, and further investigation is required to fully characterise the biological significance of NNMT inhibition across different tissues and physiological systems.
Scientific Research Context
Published studies have primarily used 5-Amino-1MQ as an experimental research tool to investigate the biological role of nicotinamide N-methyltransferase (NNMT). Across a variety of laboratory models, researchers have examined how selective inhibition of this enzyme influences nicotinamide metabolism, enzyme activity and the interconnected biochemical pathways involved in cellular metabolism. Current knowledge is based almost entirely on in vitro investigations and preclinical animal research. These experimental systems have helped expand scientific understanding of NNMT biology and its role within metabolic processes, although they are intended to explore fundamental biological mechanisms rather than establish therapeutic or clinical applications.
NNMT Biology and Metabolic Pathways
Nicotinamide N-methyltransferase (NNMT) plays an important role in a number of interconnected metabolic networks and is therefore a major subject of current biochemical research. The enzyme achieves a connection between nicotinamide metabolism and both cellular methylation and one-carbon metabolism, positioning it at the point where several biochemical processes that contribute to cellular homeostasis come together. As a result, scientists make use of selective NNMT inhibitors such as 5-Amino-1MQ in order to study the biological function of this enzyme and the way in which it contributes to tissue-specific metabolic regulation under controlled laboratory conditions.
Even though NNMT has been widely studied in preclinical research, many of its physiological functions are still the subject of ongoing investigation. Research that has been published so far remains focused on how changes in NNMT activity affect metabolic pathways, cellular adaptation and biochemical signalling in various experimental models.
NNMT Enzymatic Function
NNMT is a cytosolic methyltransferase that catalyses the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to nicotinamide, producing 1-methylnicotinamide (1-MNA) and S-adenosyl-L-homocysteine (SAH). This enzymatic reaction represents the principal biological function of NNMT and forms the basis for laboratory investigations examining enzyme activity, catalytic efficiency and substrate specificity. Experimental studies commonly assess changes in NNMT activity using enzyme kinetics, structural biology and metabolomic analysis.
Nicotinamide and NAD⁺ Metabolism
Nicotinamide acts as a key precursor in the metabolism of vitamin B3 and is involved in both the biosynthesis and the recycling of nicotinamide adenine dinucleotide (NAD⁺). Even though NNMT does not directly produce NAD⁺, its function in nicotinamide metabolism has caused it to become an important part of the larger metabolic network that controls the availability of NAD⁺ precursors. Ongoing research in the laboratory is examining how the alteration of NNMT activity affects nicotinamide turnover and the related biochemical pathways in experimental systems.
Cellular Methylation and One-Carbon Metabolism
Since the NNMT enzyme uses SAM when it catalyses a reaction, it is closely linked with the cell's use of methyl donors and one-carbon metabolism. These interconnected pathways control a number of methylation reactions which are necessary for normal cell function, such as the methylation of DNA, RNA and proteins. While published metabolomic studies have looked into how the selective inhibition of NNMT might affect the availability of methyl donors and the wider methylation networks, the downstream biological effects are still the subject of ongoing research.
Tissue-Specific Metabolic Regulation
NNMT expression varies between tissues and has therefore been investigated within several biologically active organs, including adipose tissue, liver and skeletal muscle. Research in these experimental models aims to improve understanding of tissue-specific enzyme function, metabolic adaptation and cellular energy regulation. Rather than demonstrating therapeutic outcomes, these investigations seek to characterise the physiological role of NNMT across different biological systems.
Experimental Biomarkers and Laboratory Investigation
NNMT's activity is usually assessed by means of complementary biochemical and molecular techniques. 1-Methylnicotinamide (1-MNA) is frequently employed as a measure of the enzyme's activity, and further information about the biochemical pathways linked to NNMT is obtained through various analytical methods such as liquid chromatography-mass spectrometry (LC-MS), metabolomic profiling, gene expression analysis and enzyme kinetics. Taken together, these methods allow researchers to study enzyme function, molecular interactions and metabolic responses in controlled laboratory settings.
Experimental Models Used in Published Research
The present knowledge of 5-Amino-1MQ comes from a variety of experimental models which have been developed to study the biology of nicotinamide N-methyltransferase (NNMT) under controlled laboratory conditions. Each of these models gives different information regarding enzyme activity, metabolic regulation and the biological pathways linked with NNMT. The various complementary methods have thus helped to build up the current preclinical body of evidence.
Cell Culture Models
Cell culture systems offer a controlled setting in which to study NNMT activity at the cellular level before moving on to more complicated experimental models. By using cultured cells, researchers are able to look at enzyme function, gene expression, the profiles of intracellular metabolites and molecular signalling pathways. The in vitro studies enable the specific biochemical mechanisms to be examined under carefully controlled laboratory conditions and at the same time reduce biological variability.
Adipocyte Models
Cultured adipocytes are widely used to investigate the biological role of NNMT within adipose tissue. These models enable researchers to examine cellular metabolism, lipid-related pathways and enzyme activity in fat cells while evaluating changes in metabolomic and molecular markers associated with selective NNMT inhibition.
Mouse Models
Researchers can explore NNMT in a whole physiological system using mouse models, allowing for simultaneous observation of the interactions between different tissues. Under controlled experimental conditions, they have been used in studies of metabolic regulation, tissue-specific enzyme expression, and the biological effects associated with changes in NNMT activity.
Diet-Induced Obesity Models
Diet-induced obesity models are commonly used to investigate metabolic dysfunction because they reproduce many physiological features associated with obesity in a controlled research setting. Published studies have used these models to examine NNMT biology, metabolic regulation and the biochemical pathways associated with selective enzyme inhibition while accounting for interactions between multiple organ systems.
Aged Skeletal Muscle Models
Experimental models of aged skeletal muscle have been used to investigate the role of NNMT in muscle biology during ageing. These studies combine cultured muscle cells and ageing animal models to explore enzyme expression, cellular metabolism and tissue-specific molecular pathways associated with skeletal muscle physiology.
Pharmacokinetic Studies
The pharmacokinetic studies look at the way 5-Amino-1MQ acts in experimental systems by looking at factors like absorption, distribution and bioanalytical measurement. They help in the interpretation of the preclinical results and supply valuable information about the level of exposure to the compound and the analytical evaluation carried out in laboratory research.
5-Amino-1MQ Published Research
Most of the studies on 5-Amino-1MQ have so far looked at the compound as an experimental inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT) in preclinical research. The current evidence is mainly based on laboratory studies that use cultured cells and animal models in order to investigate the biological role of NNMT in various metabolic systems. The sections that follow give a summary of the main areas covered in the published scientific literature.
Adipose Tissue Biology
Adipose tissue represents one of the most extensively investigated areas of 5-Amino-1MQ research. Published studies have examined NNMT activity within adipocytes to improve understanding of the enzyme's relationship with adipose tissue biology, lipid metabolism and cellular metabolic processes. Cell-based experiments and animal models have been used to investigate how selective inhibition of NNMT influences biochemical pathways associated with adipose tissue under controlled laboratory conditions.
Rather than focusing on therapeutic outcomes, these investigations aim to characterise the biological function of NNMT within adipose tissue and to improve scientific understanding of its role in metabolic regulation.
Metabolic Regulation
NNMT has become an important focus of research into metabolic regulation because of its involvement in pathways associated with glucose homeostasis, cellular metabolism and energy utilisation. Published investigations have examined these processes using a range of preclinical experimental models to better understand the biological role of the enzyme.
Although this body of research continues to grow, the available evidence is derived from laboratory studies rather than controlled human clinical investigations. As such, current findings should be interpreted within the context of preclinical research.
Liver Research
Due to its central function in metabolic control, the liver has been a major focus of investigations on 5-Amino-1MQ. Researchers have looked at NNMT in liver tissue to gain a better understanding of its role in liver metabolism and the biochemical pathways that are involved in normal cell function.
The majority of this work has been done with the help of preclinical animal models, providing a controlled setting in which to study metabolic processes that are specific to the liver. Even though these experimental systems have increased our scientific understanding of NNMT in hepatic tissue, the evidence that has been published is still confined to research carried out in the laboratory.
Skeletal Muscle Research
Scientific interest in NNMT has been extended from metabolic tissues to skeletal muscle biology, especially in experimental models of aging. Published research has included the use of aging animal models and cultured muscle cells to investigate the role of the enzyme in skeletal muscle and its role in cellular metabolic activities.
Current research continues to prioritise understanding NNMT biology rather than evaluating clinical applications. As in other areas of 5-Amino-1MQ research, the available evidence is derived from preclinical laboratory studies.
Gut Microbiome Research
Recent studies have looked at possible connections between NNMT inhibition and the gut microbiome in addition to tissue-specific metabolism. As part of more general metabolic biology research, published studies have evaluated changes in microbial composition within experimental animal models.
This remains an emerging area of research, with current evidence limited to preclinical laboratory studies. Further investigation is required to better understand the relationship between NNMT activity, host metabolism and microbial populations.
Limitations of Current Research
Understanding the limitations of the available evidence is just as important as understanding the findings themselves.
Although several studies have reported encouraging observations, the research remains in its early stages and important questions remain unanswered.
The evidence is overwhelmingly preclinical
Most of what is currently known about 5-Amino-1MQ comes from laboratory research using cultured cells and animal models. Although these approaches are well established for studying biological processes, they have inherent limitations and cannot be expected to mirror human physiology in its entirety.
Human clinical evidence has not been established
There are currently no widely recognised controlled clinical trials demonstrating the safety, efficacy or appropriate therapeutic use of 5-Amino-1MQ in humans. Consequently, no validated human dosage, treatment protocol or long-term safety profile has been established.
Species differences remain important
Differences in pharmacokinetic behaviour have been reported between animal species, including variation in oral bioavailability. This highlights an important limitation of preclinical research, as findings from one species cannot be assumed to translate directly to another or to humans.
Dietary intervention influenced several studies
Some of the most frequently cited metabolic studies combined 5-Amino-1MQ with substantial dietary changes. This makes it difficult to determine how much of the observed improvement resulted from NNMT inhibition alone.
Long-term effects remain unknown
Most published studies lasted only a few weeks. Questions surrounding prolonged NNMT inhibition, tissue-specific responses and long-term safety have yet to be fully investigated.
Independent replication is limited
5-Amino-1MQ has been the subject of numerous investigations, some of which came from closely associated research teams. Further independent research will improve knowledge of the chemical and support current findings.
For these reasons, current scientific evidence should be viewed as an evolving body of preclinical research rather than established clinical knowledge.
Analytical Documentation
Reliable laboratory research begins with accurate identification of the material being investigated. As a synthetic small molecule, 5-Amino-1MQ undergoes analytical verification to confirm its chemical identity, purity and batch consistency before being supplied for research purposes.
Analytical high-performance liquid chromatography (HPLC) is usually employed in order to determine chemical purity, and liquid chromatography-mass spectrometry (LC-MS) is used to verify the expected molecular mass and the identity of the compound; where appropriate, additional techniques such as nuclear magnetic resonance (NMR) spectroscopy can also be used to provide further information about the molecular structure.
Direct SARMs San Marino provides a Certificate of Analysis (CoA) together with chromatographic purity data where this is applicable. The documents enable researchers to check the identification and the analytical specifications that are stated before they start their laboratory work.
The analytical documentation can be used for identifying the product and ensuring quality, but it must not be regarded as proof of biological activity, experimental performance or clinical suitability.
Storage and Laboratory Handling
5-Amino-1MQ should be handled only by appropriately qualified personnel using suitable laboratory procedures and applicable safety practices.
Before starting any experimental work researchers must look over the specifications given with each individual product. Storage conditions will differ according to the formulation supplied and so the instructions on the relevant product page should always be followed.
In order to help maintain the integrity of the product, laboratory materials must be stored under the recommended conditions, kept free from contamination and handled with the proper laboratory equipment.
Direct SARMs San Marino supplies 5-Amino-1MQ solely for use in laboratory research and it is not intended for human consumption, for veterinary use, for diagnosis or as a therapeutic agent.
Frequently asked questions
Why choose us?
Direct SARMs San Marino is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs San Marino, we aim to make the research supply process simple, clear, and reliable.